Amy Hicks, PhD

Amy Hicks, PhD has extensive work experience in various research and leadership roles. Amy is currently working at Entrada Therapeutics as an Associate Director, leading the NEUROMUSCULAR & CARDIAC BIOLOGY GROUP. In this role, they design and analyzes in vivo studies, manages a team, and has contributed to the company's successful IPO filing package.

Prior to that, Amy worked at Korro Bio, Inc. as a Senior Scientist in the TRANSLATIONAL PHARMACOLOGY GROUP. Amy was responsible for training and managing a team, designing and running important in vivo studies, and building infrastructure for the company.

Before joining Korro Bio, Amy worked at The Jackson Laboratory as a Postdoctoral Research Associate. Amy played a key role in the lab's research on Ighbmp2-related diseases and collaborated with other institutes. Amy also served as a course director in the Summer Student Program and conducted research on U2 snRNA gene expression.

Additionally, Amy has experience as an Adjunct Instructor at the College of the Atlantic, where they taught courses on Cellular & Molecular Biology. Amy developed course curriculums, administered exams and assignments, and emphasized scientific communication.

Earlier in their career, Amy worked as a Graduate Research Fellow at the Wake Forest Institute for Regenerative Medicine and as a Research Associate at Penn State University. In these roles, they conducted research on nerve and bladder development and contributed to projects on cancer risk.

Overall, Amy Hicks, PhD has a broad range of experience in research, leadership, teaching, and collaboration across multiple institutions.

Amy Hicks, PhD, obtained their High School Diploma from Warwick High School in the year 2000. Amy then pursued their Bachelor of Science (BS) degree in both Cell/Cellular and Molecular Biology, as well as Biochemistry, at the University of Maine from 2000 to 2005. After completing their undergraduate studies, Amy went on to attend Wake Forest University Graduate School from 2007 to 2012, where they earned a Doctorate of Philosophy (PhD) in Molecular Medicine and Translational Sciences.